EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Biomarkers for acute kidney injury: a pragmatic approach

Melanie Meersch-Dini, John A Kellum

Intensive Care Medicine · 2026-04 · 52 (4) · 803-806

DOI: 10.1007/s00134-026-08296-7 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Intensive Care Medicine, online erschienen am 26.01.2026. Verfasst von Melanie Meersch-Dini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, University of Muenster, Muenster, Germany. meersch@uni-m…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Universität Münster.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The need for advancing renal diagnosticsTraditionally, the diagnosis of kidney disease has relied primarily on serum creatinine (SCr).For acute kidney injury (AKI), changes in urine output (UO) have also been recognized as a key diagnostic component, ultimately leading to the development of the Kidney Disease: Improving Global Outcomes (KDIGO) criteria in 2012 to provide a standardized definition of AKI.However, both criteria have substantial limitations, particularly with respect to early diagnosis.SCr and UO are reliable markers in patients with stable kidney function but perform less well in acute settings, where renal function may decline rapidly or fluctuate.This is especially true for the critically ill and injured as severe alterations in physiology can provoke changes in SCr and UO even when the kidney is not injured.Following kidney injury, increases in SCr are delayed (often by 24-36 h).The half-life of creatinine increases as glomerular filtration rate declines, and measured levels may be influenced by factors affecting tubular secretion.UO, in contrast, is strongly influenced by fluid balance, diuretic therapy, and urinary tract obstruction.Importantly, neither marker provides specific information regarding AKI etiology, site of injury, underlying pathophysiological mechanisms, or likelihood of recovery.Compared to either biomarker alone, the combination of SCr and UO provides more information [1], but still, these traditional measures are often inadequate when assessing for AKI.Crucially, structural kidney injury frequently precedes functional impairment, such that the

Autor:innen und Institutionen

  • Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, University of Muenster, Muenster, Germany. meersch@uni-muenster.de.
  • Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, USA.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Universität Münster

Zitieren

APA

Meersch-Dini, M., & Kellum, J. A. (2026). Biomarkers for acute kidney injury: a pragmatic approach. Intensive Care Medicine, 52(4), 803-806. https://doi.org/10.1007/s00134-026-08296-7

Vancouver

Meersch-Dini M, Kellum JA. Biomarkers for acute kidney injury: a pragmatic approach. Intensive Care Medicine. 2026;52(4):803-806. doi:10.1007/s00134-026-08296-7

BibTeX
@article{MeerschDini2026,
  author = {Meersch-Dini, Melanie and Kellum, John A},
  title = {Biomarkers for acute kidney injury: a pragmatic approach},
  journal = {Intensive Care Medicine},
  year = {2026},
  volume = {52},
  number = {4},
  pages = {803--806},
  doi = {10.1007/s00134-026-08296-7}
}
Kostenlos starten →